Effect of pyrazolidine derivatives on experimental venous thrombosis in rabbits.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001777:Blood Coagulation; D002918:Chymotrypsin / Q000032:analysis; D004195:Disease Models, Animal; D004950:Esterases / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007601:Jugular Veins / Q000201:enzymology / Q000293:injuries; D008026:Ligation; D008722:Methods; D010690:Phlebography; D011720:Pyrazoles / Q000627:therapeutic use*; D011817:Rabbits; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D013917:Thrombin / Q000032:analysis; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000473:pathology; D013927:Thrombosis / Q000139:chemically induced; D014682:Vena Cava, Inferior / Q000201:enzymology
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D004950:Esterases; D013300:Streptokinase; D002918:Chymotrypsin; D013917:Thrombin; D005341:Fibrinolysin